卓翼科技(002369.SZ):累計收到770.56萬元政府補助
格隆匯 10 月 8日丨卓翼科技(002369.SZ)公佈,公司及下屬子公司深圳市卓翼智造有限公司(以下簡稱"卓翼智造")、中廣互聯(廈門)信息科技有限公司(以下簡稱"中廣互聯")、深圳市卓博機器人有限公司(以下簡稱"卓博機器人")2020年4月至今累計收到各類政府補助金額共計770.56萬元(未經審計),其中與收益相關的各類政府補助資金共計人民幣663.56萬元,與資產相關的各類政府補助資金共計人民幣107萬元。公司收到與收益相關的各類政府補助累計達到公司最近一期經審計的歸屬於上市公司股東的淨利潤的13.21%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.